STRIDES PHARMA (longer term perspective)
Strides Pharma is in a re-accumulation phase on monthly charts. Even fundamentally its subsidiary is yet to get listed somewhere around 2022, organisation is going places
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。